CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cytokinetics (CYTK) had its price target raised by Mizuho from $84.00 to $100.00. They now have an "outperform" rating on the stock.
Cytokinetics (CYTK) had its price target raised by JPMorgan Chase & Co. from $74.00 to $75.00. They now have an "overweight" rating on the stock.
Assessing Cytokinetics (CYTK) Valuation After New MYQORZO Trial Data And Safety Outcomes [Yahoo! Finance]
Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo [Yahoo! Finance]
Form 4 CYTOKINETICS INC For: Mar 17 Filed by: Lee Sung
Form 4 CYTOKINETICS INC For: Mar 17 Filed by: Callos Andrew
Form 4 CYTOKINETICS INC For: Mar 17 Filed by: Malik Fady Ibraham
Form 4 CYTOKINETICS INC For: Mar 17 Filed by: Blum Robert I
Form 4 CYTOKINETICS INC For: Mar 18 Filed by: Callos Andrew
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.